Question

Difficulty: HardIron Triangles and Issue Networks

For decades, the Food and Drug Administration's division of drug evaluation, the House Subcommittee on Health, and the leading trade association representing pharmaceutical manufacturers maintained a closed, stable relationship that consistently resulted in expedited drug approval processes and limited external oversight. Recently, however, this relationship has been challenged by a diverse coalition of academic researchers, consumer advocacy groups, public health organizations, and media commentators demanding stricter safety trials and public database registries for clinical results. Which of the following concepts best describes the shift in this policymaking environment?

  1. A transition from a closed, stable iron triangle to a more open and fluid issue network containing multiple competing interest groups and specialistsAnswer
  2. B
    The replacement of a decentralized issue network with a highly structured iron triangle that streamlines policy implementation
  3. C
    A shift from a delegate model of representation to a trustee model of representation among members of the congressional subcommittee
  4. D
    The consolidation of bureaucratic discretionary authority into a single elite-led interest group at the expense of congressional oversight

Answer

A transition from a closed, stable iron triangle to a more open and fluid issue network containing multiple competing interest groups and specialists
The initial setup describes a classic iron triangle, consisting of a bureaucratic agency (the FDA division), a congressional committee (the House Subcommittee on Health), and an interest group (the pharmaceutical trade association) working in a mutually beneficial, closed loop. When outside actors such as academics, consumer advocates, and the media intervene, this closed relationship is disrupted and becomes an issue network—a much broader, more fluid web of individuals and groups who discuss and advocate for policy changes.

Step-by-Step Solution

1
Analyze the initial relationship described in the scenario.
The alliance consists of a bureaucratic agency (Food and Drug Administration's division of drug evaluation), a congressional committee (House Subcommittee on Health), and an interest group (trade association representing pharmaceutical manufacturers).
This three-way, stable relationship defines a traditional iron triangle.
2
Identify the nature of the change introduced in the scenario.
The stable relationship is challenged by academic researchers, consumer advocates, public health organizations, and media commentators.
The introduction of multiple, diverse, and competing actors who are not part of the core alliance broadens the policymaking environment into a fluid network.
3
Select the concept that accurately describes this structural transition.
The transition from a closed iron triangle to an open, fluid issue network.
Issue networks are characterized by their openness, the inclusion of policy specialists and researchers, and their fluid, less stable nature compared to iron triangles.

Key Concept

The difference between iron triangles (closed, stable three-way relationships among agencies, committees, and interest groups) and issue networks (broader, fluid coalitions of diverse actors trying to influence policy)
Rate this question